Alnylam Pharmaceuticals in Cambridge, MA seeks a Senior/Executive Director, Development Program Lead to shape and drive two early-stage rare disease programs in hepatobiliary space. You will build integrated development strategies and lead execution through critical milestones, guiding cross-functional teams and making investment decisions based on emerging data.
The role requires a leader who thrives in ambiguity, demonstrates strong strategic judgment, and communicates effectively with senior
#J-18808-LjbffrSenior Program Lead - Early-Stage Rare Disease in cambridge at Unknown Company
This position is listed as full time and onsite.